Related Experiment Video

Updated: Aug 7, 2026

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
10:59

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment

Published on: November 23, 2017

[Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) in children with ulcerative

Ewa Grabarczyk1, Anna Szaflarska-Popławska, Krzysztof Góralczyk

  • 1Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum w Bydgoszczy, Katedra Patofizjologii Zakład Zaburzeń Hemostazy.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|June 20, 2006
PubMed

Insights

Children with ulcerative colitis show elevated levels of plasminogen activator inhibitor-1 (PAI-1), suggesting its role in the inflammatory processes of this condition.

Area of Science:

  • Pediatric Gastroenterology
  • Hemostasis and Thrombosis
  • Inflammatory Bowel Disease

Context:

  • Ulcerative colitis (UC) in children presents complex pathogenesis with debated roles of hemostasis disturbances.
  • Existing literature shows discrepancies in findings and interpretations regarding coagulation factors in pediatric UC.

Purpose:

  • To assess the levels of tissue plasminogen activator (t-PA) and its inhibitor (PAI-1) in children diagnosed with ulcerative colitis.
  • To investigate the potential involvement of t-PA and PAI-1 in the inflammatory mechanisms underlying pediatric UC.

Summary:

  • This study analyzed 22 children with UC (mean age 15.55 years) and a control group of 22 children with celiac disease.
  • Measurements of t-PA and PAI-1 antigen levels were performed using ELISA.
  • Results indicated similar concentrations of t-PA antigen between groups, but a statistically significant higher concentration of PAI-1 antigen in children with UC.

Impact:

  • The findings suggest that elevated PAI-1 concentrations in pediatric UC patients may indicate its participation in the inflammatory response and disease-induced changes in the colon mucosa.
  • This research contributes to understanding the hemostatic alterations in pediatric ulcerative colitis, potentially informing future therapeutic strategies.
Abstract

More Related Videos

Murine Model of Intestinal Ischemia-reperfusion Injury07:07

Murine Model of Intestinal Ischemia-reperfusion Injury

Published on: May 11, 2016

Related Concept Videos

Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...